• Company Information
      • About the Report
      • Documents
      • Outstanding Payments (MSME)
      • Complaints
      • Directors
      • Same Address Companies
      • Charges
      • Contact Details
      • Products & Services
      • Balance Sheet
      • Profit & Loss
      • Fund Raising
      • Shareholders & Investors
      • Board Meetings
      • Auditors

      RAYDON PHARMACEUTICALS PRIVATE LIMITED

      CIN: U74999PN2015PTC156885
      Purchase Report

      RAYDON PHARMACEUTICALS PRIVATE LIMITED (CIN: U74999PN2015PTC156885) is a Private company incorporated on 15 Oct 2015. It is classified as Non-government company and is registered at Registrar of Companies, Pune. Its authorized share capital is Rs. 100000.00 and its paid up capital is Rs. 100000.00.

      RAYDON PHARMACEUTICALS PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 30 Sep 2023. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2023-03-31.RAYDON PHARMACEUTICALS PRIVATE LIMITED's NIC code is 7499 (which is part of its CIN). As per the NIC code, it is inolved in Other business activities n.e.c.[This class includes service activities generally delivered to commercial clients].

      Directors of RAYDON PHARMACEUTICALS PRIVATE LIMITED are JITENDRA NAVINCHANDRA PAREKH, AKSHAY JAWAHAR MITHANI, POOJA JAWAHAR MITHANI, and KUSHAL JITENDRA PAREKH.

      RAYDON PHARMACEUTICALS PRIVATE LIMITED's Corporate Identification Number (CIN) is U74999PN2015PTC156885 and its registration number is 156885. Users may contact RAYDON PHARMACEUTICALS PRIVATE LIMITED on its Email address - [email protected]. Registered address of RAYDON PHARMACEUTICALS PRIVATE LIMITED is Office No. 503, 5th Floor ,Shivai Apartment 1,CTS No 257, F.Pl. No. 587, Near Indian Oil Petrol Pump, Dandekar Pool, Parvati , Pune City, Maharashtra, India - 411030.

      Current status of RAYDON PHARMACEUTICALS PRIVATE LIMITED is - Active.

      Basic Information

      • CIN
      • Name
      • Listed on Stock Exchange
      • Company Status
      • ROC
      • Registration Number
      • Company Category
      • Company Sub Category
      • Class of Company
      • Date of Incorporation
      • Age of Company
      • Activity
      • Number of Members

      Annual Compliance Status

      • Date of Last Annual General Meeting
      • Date of Last Filed Balance Sheet

      Key Numbers

      • Authorised Share Capital
      • Paid-up Share Capital
      • Total Assets
      • Revenue
      • Profit
      • Salaries & Other Employee Benefit Expenses
      Want to see how this company compares within its industry or analyse broader market trends?
      Explore Prime Research for Industry & Economic Insights

      Previous Names

      Previous CINs

      ZaubaCorp's company report for RAYDON PHARMACEUTICALS includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.

      Purchase Report

      All companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.

      Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.

      Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of RAYDON PHARMACEUTICALS

      Purchase full report of RAYDON PHARMACEUTICALS

      Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if RAYDON PHARMACEUTICALS pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.

      Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay

      This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.

      Director Complaints
      Date DIN Cessation Date Cessation Reason Complaint
      Serious Complaints
      Date Complaint Other Details
      Investor Complaints & Other Complaints
      Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details

      Current Directors & Key Managerial Personnel of RAYDON PHARMACEUTICALS
      DIN Director Name Designation Appointment Date
      07311621 JITENDRA NAVINCHANDRA PAREKH Director 2015-10-15
      10218515 AKSHAY JAWAHAR MITHANI Director 2023-07-03
      10218523 POOJA JAWAHAR MITHANI Director 2023-07-03
      07298171 KUSHAL JITENDRA PAREKH Director 2015-10-15
      Past Directors & Key Managerial Personnel of RAYDON PHARMACEUTICALS
      DIN Director Name Designation Appointment Date Cessation
      10218515 AKSHAY JAWAHAR MITHANI Additional Director - 2023-09-29
      10218523 POOJA JAWAHAR MITHANI Additional Director - 2023-09-29
      01713606 ASHOK RAMCHANDRA MITTAL Director - 2023-06-10
      07280606 NEERAJ NARESH MITTAL Director - 2023-06-10
      Other Directorships of JITENDRA NAVINCHANDRA PAREKH
      Company Name CIN Designation Appointment Date Cessation
      Other Directorships of AKSHAY JAWAHAR MITHANI
      Company Name CIN Designation Appointment Date Cessation
      Other Directorships of POOJA JAWAHAR MITHANI
      Company Name CIN Designation Appointment Date Cessation
      Other Directorships of ASHOK RAMCHANDRA MITTAL
      Company Name CIN Designation Appointment Date Cessation
      EMERALD GRIHANIRMAN LLP AAA-5311 Partner 2011-06-22 Ongoing
      MITTAL VASTU RACHANA LLP AAC-0383 Designated Partner 2014-01-29 Ongoing
      MITTAL HAPPY COWS DAIRY FARMS LLP AAG-6183 Partner 2016-06-09 Ongoing
      MITTAL GLOBAL PACKPRO LLP AAL-5316 Designated Partner 2018-02-22 Ongoing
      GREENSUTRA FARMS LLP AAM-1975 Designated Partner - 2021-02-06
      CENTERLANDS REALTY LLP AAM-3200 Designated Partner 2020-01-09 Ongoing
      AUSTRA SPACES LLP AAZ-3127 Designated Partner 2021-11-02 Ongoing
      Mitsui Stone Crusher LLP ABC-6639 Designated Partner 2022-10-06 Ongoing
      MITSUI STONE CRUSHER PRIVATE LIMITED U14106PN2005PTC020859 Director 2005-06-10 Ongoing
      MITTAL VEGOILS INDIA PRIVATE LIMITED U15144PN1999PTC013671 Director 1999-05-27 Ongoing
      JINDAL MITTAL PROMOTERS AND BUILDERS PRIVATE LIMITED U45202PN1999PTC013965 Additional Director - 2018-09-29
      JINDAL MITTAL PROMOTERS AND BUILDERS PRIVATE LIMITED U45202PN1999PTC013965 Director 2018-09-29 Ongoing
      JINDAL MITTAL BUILDERS PRIVATE LIMITED U45202PN2000PTC015554 Director 2002-03-23 Ongoing
      JINDAL MITTAL PROPERTIES PRIVATE LIMITED U45202PN2001PTC016537 Director 2003-09-29 Ongoing
      JINDAL MITTAL GRAHA NIRMAN PRIVATE LIMITED U45202PN2002PTC016883 Director 2002-04-24 Ongoing
      TPPL MP JOINT VENTURE PRIVATE LIMITED U45203PN2017PTC173613 Director 2017-11-29 Ongoing
      SUN TELESERVICES PRIVATE LIMITED U64202PN2006PTC128596 Director - 2016-03-01
      SARASWATIDEVI RAMCHANDRA MITTAL FOUNDATION U85300PN2020NPL189519 Director 2020-01-30 Ongoing
      Other Directorships of NEERAJ NARESH MITTAL
      Company Name CIN Designation Appointment Date Cessation
      MITTAL VASTU RACHANA LLP AAC-0383 Partner 2016-05-14 Ongoing
      MITTAL HAPPY COWS DAIRY FARMS LLP AAG-6183 Designated Partner 2016-06-09 Ongoing
      MITTAL VASTUSHILP LLP AAH-5970 Designated Partner 2016-10-13 Ongoing
      MITTAL GLOBAL PACKPRO LLP AAL-5316 Designated Partner 2017-12-28 Ongoing
      GREENSUTRA FARMS LLP AAM-1975 Designated Partner 2018-03-09 Ongoing
      PUNE URBAN VENTURES LLP ACH-8517 Designated Partner 2024-06-19 Ongoing
      LINEA DESIGNS PRIVATE LIMITED U36109PN2022PTC215683 Director 2022-10-21 Ongoing
      Other Directorships of KUSHAL JITENDRA PAREKH
      Company Name CIN Designation Appointment Date Cessation

      CIN Company Name Company Address
      View all companies with similar address

      Charge ID Charge Creation Date Charge Modification Date Charge Closure Date Assets Under Charge Amount Charge Holder

      • Email ID
      • Website
      • Address

      This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.

      Financial Year Business Activity Code Business Activity Description Percentage of Turnover

      Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

      2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
      Download Audited Financials
      EQUITY AND LIABILITIES
         Shareholder's funds
            Share Capital
            Reserves & Surplus
            Money Received Against Share Warrants
         Share Application Money Pending Allotment
         Non-current Liabilities
            Long-term borrowings
            Deferred tax liabilities
            Other Long Term Liabilities
            Long Term Provisions
         Current Liabilities
            Short-term borrowings
            Trade Payables
            Other Current Liabilities
            Short Term Provisions
      Total Equity and Liabilities
      ASSETS
         Non-current Assets
            Fixed Assets
               Tangible Assets
               Intangible Assets
               Capital Work In Progress
               Intangible Assets Under Development
            Non-current Investments
            Deferred Tax Assets (net)
            Long-term Loans & Advances
            Other Non-current Assets
         Current Assets
            Current Investments
            Inventories
            Trade receivables
            Cash & Cash Equivalents
            Short-term Loans & Advances
            Other Current Assets
      Total Assets

      Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.

      2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31 2016-03-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31
      Download Audited Financials
      REVENUE FROM OPERATIONS
         Domestic Turnover
            Sale of Goods Manufactured
            Sale of Goods Traded
            Sale of Supple of Services
         Export Turnover
            Sale of Goods Manufactured
            Sale of Goods Traded
            Sale or Supply of Services
         Other Income
      Total Revenue From Operations
      EXPENSES
         Cost of Materials Consumed
         Purchases of Stock in Trade
         Change in Inventories of
            Finished Goods
            Work in Progress
            Stock in Trade
         Employee benefit Expenses
         Managerial Remuneration
         Payment to Auditors
         Insurance Expenses
         Power & Fuel
         Finance Cost
         Depreciation & Amortization Expenses
         Other Expenses
      Total Expenses
      Profit before Exceptional Items, Extraordinary Items and Tax
         Exceptional Items
      Profit before Extraordinary items and Tax
         Extraordinary Items
      Profit before Tax
         Tax Expense
            Current Tax
            Deferred Tax
      Profit/Loss after Tax from Continuing Operations
      Profit/Loss after Tax from Discontinuing Operations
         Tax Expense of Discontinuing Operations
      Total Profit/Loss
      Earnings per Equity Share (EPS) before Extraordinary Items
         Basic
         Diluted
      Earnings per Equity Share (EPS) after Extraordinary Items
         Basic
         Diluted

      This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.

      Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments

      This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.

      Company Identifier Name Percentage of Shares Held

      This section contains list of board resolutions reported by the company to the Registrar of Companies.

      Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents

      This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.

      Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report

      As on: 2026-07-13

      Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.

      Purchase our hand crafted financial report for $ 9.99